scPharmaceuticals Inc

(NASDAQ:SCPH)

Latest On scPharmaceuticals Inc (SCPH):

Date/Time Type Description Signal Details
2023-05-20 04:36 ESTNewsscPharmaceuticals: Furoscix Firing On All Cylinders In Q1, Bullish Than EverN/A
2023-05-11 10:11 ESTNewsscPharmaceuticals Inc. (SCPH) Q1 2023 Earnings Call TranscriptN/A
2023-05-10 20:15 ESTNewsscPharmaceuticals GAAP EPS of -$0.28 beats by $0.08, revenue of $2.1M beats by $0.53MN/A
2023-03-28 11:24 ESTNewsscPharmaceuticals: Furoscix Launch And Market Access; A Promising OutlookN/A
2023-03-24 00:13 ESTNewsscPharmaceuticals stock surges ~20% amid Q4 results with eye on Furoscix future revenueN/A
2023-03-23 07:35 ESTNewsscPharmaceuticals Inc. (SCPH) Q4 2022 Earnings Call TranscriptN/A
2023-03-22 16:56 ESTNewsscPharmaceuticals GAAP EPS of -$0.27 beats by $0.12N/A
2023-01-24 19:16 ESTNewsscPharmaceuticals: Undervalued, De-Risked Cardiology Commercial Biotech, Initiating With A BuyN/A
2022-12-20 00:16 ESTNewsscPharmaceuticals names Rachael Nokes as CFON/A
2022-11-22 07:31 ESTNewsscPharmaceuticals announces stock offeringN/A
2022-11-13 04:21 ESTNewsscPharmaceuticals Inc. (SCPH) Q3 2022 Earnings Call TranscriptN/A
2022-11-10 05:26 ESTNewsscPharmaceuticals GAAP EPS of -$0.37, guidance loweredN/A
2022-10-20 05:52 ESTNewsscPharmaceuticals: Furoscix Approval A Potential Paradigm Shift For Heart Failure PatientsN/A
2022-10-11 20:12 ESTNewsscPharmaceuticals: Not All Approvals Cause A Stock To Go UpN/A
2022-10-10 16:52 ESTNewsFDA approves scPharmaceuticals Furoscix to treat congestion in heart failureN/A
2022-08-10 05:21 ESTNewsscPharmaceuticals GAAP EPS of -$0.35 misses by $0.05N/A
2022-07-12 14:52 ESTNewsscPharma says key goals in mid-stage study favored heart failure therapyN/A
2022-05-16 18:42 ESTNewsscPharmaceuticals gains as FDA accepts marketing application for heart failure drugN/A
2022-05-16 18:42 ESTNewsscPharmaceuticals GAAP EPS of -$0.26N/A
2022-04-12 16:51 ESTNewsscPharmaceuticals refiles for FDA approval of Furoscix for heart failureN/A
2022-03-23 12:25 ESTNewsscPharmaceuticals GAAP EPS of -$0.27 beats by $0.08N/A
2021-11-09 16:26 ESTNewsscPharmaceuticals EPS misses by $0.01N/A
2021-08-26 19:31 ESTNewsscPharmaceuticals: We Still See A High Probability Of Success For FUROSCIXN/A
2021-08-11 07:37 ESTNewsscPharmaceuticals EPS misses by $0.06N/A
2021-07-21 23:02 ESTNewsscPharmaceuticals perks up on positive data for FUROSCIX in heart failure studyN/A
2021-03-23 09:30 ESTNewsscPharmaceuticals EPS misses by $0.22N/A
2021-03-16 21:58 ESTAnalyst RatingThe Analyst Target Price has increased from $11 to $12.Buy
2021-02-27 01:19 ESTNewsscPharmaceuticals (SCPH) Presents At SVB Leerink 10th Annual Global Healthcare Conference - SlideshowN/A
2021-02-23 20:30 ESTNewsscPharmaceuticals reports FDA meeting results regarding Furoscix applicationN/A
2021-01-15 15:17 ESTNewsscPharmaceuticals Inc.: The FUROSCIX CRLs Have Created An Excellent Buying OpportunityN/A
2020-12-09 05:15 ESTAnalyst RatingThe Analyst Target Price has decreased from $12 to $11.Neutral
2020-12-08 05:14 ESTAnalyst RatingThe Analyst Target Price has decreased from $13.75 to $12.Neutral
2020-12-07 09:42 ESTNewsFDA rejects scPharma's Furoscix application, againN/A
2020-12-01 13:03 ESTAnalyst RatingThe Analyst Target Price has increased from $13.5 to $13.75.Buy
2020-11-26 21:29 ESTFinancialsCompany financials have been released.Neutral
2020-11-20 21:01 ESTFinancialsCompany financials have been released.Neutral
2020-11-17 21:09 ESTFinancialsCompany financials have been released.Neutral
2020-11-17 18:56 ESTNewsscPharmaceuticals EPS beats by $0.05N/A
2020-11-17 05:21 ESTEarnings EstimateAn EPS average of -$0.46 is estimated for the quarter ending on March 31, 2021.Sell
2020-11-08 00:50 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 17:05 ESTFinancialsCompany financials have been released.Neutral
2020-10-30 14:37 ESTAnalyst RatingThe Analyst Target Price has increased from $13.25 to $13.5.Buy
2020-09-26 13:59 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 06:12 ESTFinancialsCompany financials have been released.Neutral
2020-08-22 09:02 ESTNewsScPharma inks supply agreement with West PharmaN/A
2020-08-15 13:40 ESTFinancialsCompany financials have been released.Neutral
2020-08-14 17:37 ESTFinancialsCompany financials have been released.Neutral
2020-08-14 10:04 ESTFinancialsCompany financials have been released.Neutral
2020-08-14 02:15 ESTNewsscPharmaceuticals EPS beats by $0.03N/A
2020-08-06 21:49 ESTFinancialsCompany financials have been released.Neutral

About scPharmaceuticals Inc (SCPH):

scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is Furoscix that consists of proprietary buffered formulation of furosemide, which is delivered through the SmartDose drug delivery system for treatment of congestion in decompensated heart failure patients. Its product pipeline also includes scCeftriaxone, an antibiotic to treat infections caused by gram-positive and gram-negative organisms; and scCarbapenem program, an antibiotic for treating infections caused by gram-negative organisms. The company has a development agreement with West Pharmaceutical Services, Inc. to incorporate SmartDose drug delivery system with Furoscix. The company was founded in 2013 and is headquartered in Burlington, Massachusetts.

SCPH Quotes by TradingView

See Advanced Chart

General

  • Name scPharmaceuticals Inc
  • Symbol SCPH
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 26
  • Fiscal Year EndDecember
  • IPO Date2017-11-17
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://www.scpharmaceuticals.com
View More

Valuation

  • Price/Book (Most Recent Quarter) 2.15
View More

Financials

  • Most Recent Quarter 2020-09-30
  • Next Quarter EPS Estimate -$0.46
  • Return on Assets -22%
  • Return on Equity -48%
  • Earnings Per Share -$1.45
  • Revenue Per Share $0
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 190.15 million
  • EBITDA -25816000
  • Analyst Target Price $12
  • Book Value Per Share $3.29
View More

Share Statistics

  • Shares Outstanding 27.32 million
  • Shares Float 8.2 million
  • % Held by Insiders 851%
  • % Held by Institutions 65.77%
  • Shares Short 309510
  • Shares Short Prior Month 300460
  • Short Ratio 3.44
  • Short % of Float 2%
  • Short % of Shares Outstanding 1%
View More

Technicals

  • Beta 0.41
  • 52 Week High $11.99
  • 52 Week Low $5
  • 50 Day Moving Average 7.11
  • 200 Day Moving Average 7.46
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

scPharmaceuticals Inc (SCPH) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

scPharmaceuticals Inc (SCPH) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-09-302020-11-16$N/A-$0.33-$0.3711.6%
2020-06-302020-08-13$N/A-$0.36-$0.4213.61%
2020-03-312020-05-12$N/A-$0.35-$0.5435.19%
2019-12-312020-03-24$N/A-$0.58-$0.52-12.25%
2019-09-302019-11-12$N/A-$0.33-$0.4220.81%
2019-06-302019-08-07$N/A-$0.39-$0.4920.41%
2019-03-312019-05-08$N/A-$0.47-$0.494.08%
2018-12-312019-03-21$N/A-$0.27-$0.4539.33%
2018-09-302018-11-13$N/A-$0.31-$0.5442.06%
2018-06-302018-08-14$N/A-$0.53-$0.576.19%
2018-03-312018-05-07$N/A-$0.47-$0.506%
2017-12-312018-03-20$N/A-$0.46-$0.519.22%
2017-09-302017-11-17$N/A-$0.30

scPharmaceuticals Inc (SCPH) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

scPharmaceuticals Inc (SCPH) Chart:

scPharmaceuticals Inc (SCPH) News:

Below you will find a list of latest news for scPharmaceuticals Inc (SCPH) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

scPharmaceuticals Inc (SCPH) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2024-05-172.53.7CALL0 1442.7TRUE00
2024-05-1750.3CALL0 15896.65FALSE00
2024-05-177.50.54CALL0 890FALSE00
2024-05-17100.2CALL0 150FALSE00
2024-05-1712.50.05CALL0 5010FALSE00
2024-05-17150.12CALL0 460FALSE00
2024-05-172.50PUT0 00FALSE00
2024-05-1750.6PUT0 2443.64TRUE00
2024-05-177.52.2PUT0 11176.51TRUE00
2024-05-17100PUT0 0270.84TRUE00
2024-05-1712.50PUT0 0346.49TRUE00
2024-05-17150PUT0 0368.26TRUE00
2024-06-212.50CALL0 0199.21TRUE00
2024-06-2150CALL0 083.67FALSE00
2024-06-217.50CALL0 00FALSE00
2024-06-212.50PUT0 00FALSE00
2024-06-2150PUT0 080.06TRUE00
2024-06-217.50PUT0 0235.51TRUE00
2024-08-162.52.25CALL0 10182.05TRUE00
2024-08-1650.8CALL0 5772.88FALSE00
2024-08-167.50.27CALL0 1690.46FALSE00
2024-08-16100.16CALL0 1000FALSE00
2024-08-162.50PUT0 00FALSE00
2024-08-1650.55PUT0 178.65TRUE00
2024-08-167.50PUT0 075.75TRUE00
2024-08-16100PUT0 0149.24TRUE00
2024-11-152.50CALL0 0249.62TRUE00
2024-11-1550CALL0 067.22FALSE00
2024-11-157.50.45CALL0 672.96FALSE00
2024-11-15100CALL0 073.95FALSE00
2024-11-152.50PUT0 076.62FALSE00
2024-11-1550PUT0 075.72TRUE00
2024-11-157.52.16PUT0 176.25TRUE00
2024-11-15100PUT0 0108.28TRUE00
2024-12-202.53.1CALL0 8230.17TRUE00
2024-12-2051.25CALL0 4170.03FALSE00
2024-12-207.50.45CALL0 66567.03FALSE00
2024-12-20100.55CALL0 19976.11FALSE00
2024-12-2012.50.4CALL0 1170FALSE00
2024-12-202.50.27PUT0 2575.56FALSE00
2024-12-2051PUT0 26572.55TRUE00
2024-12-207.50PUT0 075.92TRUE00
2024-12-20105PUT0 2667.75TRUE00
2024-12-2012.50PUT0 0174.18TRUE00

Latest SCPH Trades:

Date Shares Price
Jun 13, 2022 5:26 PM EST14$4.49
Jun 13, 2022 5:38 PM EST14$4.49
Jun 13, 2022 5:59 PM EST14$4.49
Jun 13, 2022 7:48 PM EST10$4.515
Jun 13, 2022 7:59 PM EST100$4.43

scPharmaceuticals Inc (SCPH) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924320018277/0000899243-20-018277-index.htm
2019-02-08UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1604950/000000000019001629/0000000000-19-001629-index.htm
2017-11-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924317027190/0000899243-17-027190-index.htm
2017-11-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924317027196/0000899243-17-027196-index.htm
2017-11-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924317027197/0000899243-17-027197-index.htm
2017-11-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924317027198/0000899243-17-027198-index.htm
2017-11-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924317027200/0000899243-17-027200-index.htm
2017-11-213Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924317027203/0000899243-17-027203-index.htm
2017-11-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924317027391/0000899243-17-027391-index.htm
2017-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924317029322/0000899243-17-029322-index.htm
2018-01-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924318001522/0000899243-18-001522-index.htm
2018-01-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924318001523/0000899243-18-001523-index.htm
2018-01-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924318001525/0000899243-18-001525-index.htm
2018-02-134/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924318003707/0000899243-18-003707-index.htm
2018-06-213Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924318017623/0000899243-18-017623-index.htm
2018-06-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924318017624/0000899243-18-017624-index.htm
2018-06-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924318017630/0000899243-18-017630-index.htm
2018-06-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924318017632/0000899243-18-017632-index.htm
2018-06-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924318017633/0000899243-18-017633-index.htm
2018-06-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924318017634/0000899243-18-017634-index.htm
2018-06-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924318017635/0000899243-18-017635-index.htm
2018-06-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924318017636/0000899243-18-017636-index.htm
2018-07-243Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924318020520/0000899243-18-020520-index.htm
2018-07-243Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924318020521/0000899243-18-020521-index.htm
2018-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924318020522/0000899243-18-020522-index.htm
2018-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924318020523/0000899243-18-020523-index.htm
2019-03-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924319006445/0000899243-19-006445-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924319017634/0000899243-19-017634-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924319017635/0000899243-19-017635-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924319017637/0000899243-19-017637-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924319017638/0000899243-19-017638-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924319017639/0000899243-19-017639-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924319017642/0000899243-19-017642-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924319017643/0000899243-19-017643-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924319017644/0000899243-19-017644-index.htm
2019-12-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924319029406/0000899243-19-029406-index.htm
2020-01-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924320001192/0000899243-20-001192-index.htm
2020-01-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924320001194/0000899243-20-001194-index.htm
2020-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924320016162/0000899243-20-016162-index.htm
2020-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924320016163/0000899243-20-016163-index.htm
2020-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924320016164/0000899243-20-016164-index.htm
2020-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924320016165/0000899243-20-016165-index.htm
2020-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924320016166/0000899243-20-016166-index.htm
2020-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924320016167/0000899243-20-016167-index.htm
2020-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924320016168/0000899243-20-016168-index.htm
2020-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924320016169/0000899243-20-016169-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924320018277/0000899243-20-018277-index.htm
2020-07-133Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924320018996/0000899243-20-018996-index.htm
2020-07-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000089924320019000/0000899243-20-019000-index.htm
2017-12-01SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1604950/000094787117000981/0000947871-17-000981-index.htm
2018-01-26SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1604950/000094787118000064/0000947871-18-000064-index.htm
2020-03-27SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1604950/000094787120000300/0000947871-20-000300-index.htm
2020-05-26SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1604950/000094787120000512/0000947871-20-000512-index.htm
2020-05-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000094787120000513/0000947871-20-000513-index.htm
2017-12-04SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1604950/000110465917071638/0001104659-17-071638-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1604950/000110465920021904/0001104659-20-021904-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000110465920022837/0001104659-20-022837-index.htm
2020-02-214/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000110465920023928/0001104659-20-023928-index.htm
2020-03-31SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1604950/000110465920041157/0001104659-20-041157-index.htm
2020-06-03SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1604950/000110465920069253/0001104659-20-069253-index.htm
2017-11-27SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1604950/000114420417060942/0001144204-17-060942-index.htm
2017-12-11SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1604950/000114420417063136/0001144204-17-063136-index.htm
2019-04-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000114420419019689/0001144204-19-019689-index.htm
2018-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1604950/000119312518042997/0001193125-18-042997-index.htm
2018-03-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604950/000119312518089540/0001193125-18-089540-index.htm
2018-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604950/000119312518154480/0001193125-18-154480-index.htm
2018-05-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604950/000119312518179561/0001193125-18-179561-index.htm
2018-06-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604950/000119312518191084/0001193125-18-191084-index.htm
2018-06-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604950/000119312518194510/0001193125-18-194510-index.htm
2018-06-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604950/000119312518197936/0001193125-18-197936-index.htm
2018-07-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604950/000119312518224769/0001193125-18-224769-index.htm
2018-08-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604950/000119312518247916/0001193125-18-247916-index.htm
2018-08-28S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1604950/000119312518260582/0001193125-18-260582-index.htm
2018-09-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604950/000119312518269246/0001193125-18-269246-index.htm
2018-10-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604950/000119312518301489/0001193125-18-301489-index.htm
2018-10-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604950/000119312518303628/0001193125-18-303628-index.htm
2018-11-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604950/000119312518324899/0001193125-18-324899-index.htm
2018-11-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604950/000119312518335203/0001193125-18-335203-index.htm
2019-01-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604950/000119312519001554/0001193125-19-001554-index.htm
2019-01-03S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1604950/000119312519001560/0001193125-19-001560-index.htm
2019-01-03S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1604950/000119312519001570/0001193125-19-001570-index.htm
2019-01-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604950/000119312519019764/0001193125-19-019764-index.htm
2019-02-07CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1604950/000119312519031002/0001193125-19-031002-index.htm
2019-03-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604950/000119312519081494/0001193125-19-081494-index.htm
2019-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604950/000119312519140543/0001193125-19-140543-index.htm
2019-06-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604950/000119312519165105/0001193125-19-165105-index.htm
2019-06-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604950/000119312519177625/0001193125-19-177625-index.htm
2019-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604950/000119312519214672/0001193125-19-214672-index.htm
2019-08-23424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1604950/000119312519228020/0001193125-19-228020-index.htm
2019-08-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604950/000119312519228026/0001193125-19-228026-index.htm
2019-09-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604950/000119312519247390/0001193125-19-247390-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604950/000119312519289319/0001193125-19-289319-index.htm
2020-03-23SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1604950/000119312520082513/0001193125-20-082513-index.htm
2020-03-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604950/000119312520083166/0001193125-20-083166-index.htm
2020-03-24S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1604950/000119312520083819/0001193125-20-083819-index.htm
2020-05-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604950/000119312520139772/0001193125-20-139772-index.htm
2020-05-20424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1604950/000119312520147282/0001193125-20-147282-index.htm
2020-05-22424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1604950/000119312520149176/0001193125-20-149176-index.htm
2020-05-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604950/000119312520149214/0001193125-20-149214-index.htm
2020-06-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604950/000119312520165709/0001193125-20-165709-index.htm
2020-07-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604950/000119312520190819/0001193125-20-190819-index.htm
2020-07-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604950/000119312520199136/0001193125-20-199136-index.htm
2020-08-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604950/000119312520218282/0001193125-20-218282-index.htm
2020-08-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1604950/000119312520225629/0001193125-20-225629-index.htm
2020-05-283Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000120919120032809/0001209191-20-032809-index.htm
2020-05-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1604950/000120919120032812/0001209191-20-032812-index.htm
2018-03-2110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1604950/000156459018006366/0001564590-18-006366-index.htm
2018-04-30DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1604950/000156459018009817/0001564590-18-009817-index.htm
2018-04-30DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1604950/000156459018009832/0001564590-18-009832-index.htm
2018-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1604950/000156459018011269/0001564590-18-011269-index.htm
2018-08-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1604950/000156459018021584/0001564590-18-021584-index.htm
2018-11-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1604950/000156459018029140/0001564590-18-029140-index.htm
2019-03-2110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1604950/000156459019008726/0001564590-19-008726-index.htm
2019-04-30DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1604950/000156459019014297/0001564590-19-014297-index.htm
2019-04-30DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1604950/000156459019014307/0001564590-19-014307-index.htm
2019-05-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1604950/000156459019017242/0001564590-19-017242-index.htm
2019-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1604950/000156459019030027/0001564590-19-030027-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1604950/000156459019042889/0001564590-19-042889-index.htm
2020-03-2410-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1604950/000156459020012500/0001564590-20-012500-index.htm
2020-04-27DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1604950/000156459020018809/0001564590-20-018809-index.htm
2020-04-27DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1604950/000156459020018811/0001564590-20-018811-index.htm
2020-05-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1604950/000156459020024648/0001564590-20-024648-index.htm
2020-08-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1604950/000156459020039992/0001564590-20-039992-index.htm
2019-02-11EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1604950/999999999519000164/9999999995-19-000164-index.htm

scPharmaceuticals Inc (SCPH) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of scPharmaceuticals Inc (SCPH). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 851%
Institutional Ownership: 6577%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-05-21ORBIMED ADVISORS LLC10% Share HolderBuy231,200.008.651,999,880.00231,200.00https://www.sec.gov/Archives/edgar/data/1604950/000094787120000513/0000947871-20-000513-index.htm
2017-11-21Invest A/S Lundbeckfond10% Share HolderBuy654,762.0014.009,166,668.003,183,986.00https://www.sec.gov/Archives/edgar/data/1604950/000089924317027197/0000899243-17-027197-index.htm
2020-02-14RA CAPITAL MANAGEMENT, L.P.10% Share HolderBuy271,993.008.202,230,342.603,247,005.00https://www.sec.gov/Archives/edgar/data/1604950/000110465920022837/0001104659-20-022837-index.htm
2019-04-11RA CAPITAL MANAGEMENT, LLC10% Share HolderBuy389,862.002.701,052,627.403,247,005.00https://www.sec.gov/Archives/edgar/data/1604950/000114420419019689/0001144204-19-019689-index.htm
2017-11-21PHARMACEUTICAL INDUSTRIES LTD SUN10% Share HolderBuy357,143.0014.005,000,002.00357,143.00https://www.sec.gov/Archives/edgar/data/1604950/000089924317027391/0000899243-17-027391-index.htm
2020-05-21ORBIMED ADVISORS LLC10% Share HolderBuy1,156,083.008.6510,000,117.954,565,948.00https://www.sec.gov/Archives/edgar/data/1604950/000094787120000513/0000947871-20-000513-index.htm
2020-06-30John H TuckerPresident and CEOBuy42,250.0047,250.00https://www.sec.gov/Archives/edgar/data/1604950/000089924320018277/0000899243-20-018277-index.htm
2019-12-13John H TuckerPresident and CEOBuy5,000.005.2426,188.505,000.00https://www.sec.gov/Archives/edgar/data/1604950/000089924319029406/0000899243-19-029406-index.htm
2017-12-19LEONARD D SCHAEFFERDirectorBuy22,631.001.6637,567.4657,449.00https://www.sec.gov/Archives/edgar/data/1604950/000089924317029322/0000899243-17-029322-index.htm
2020-05-26Andrew J. Schwab10% Share HolderBuy578,034.008.654,999,994.10578,034.00https://www.sec.gov/Archives/edgar/data/1604950/000120919120032812/0001209191-20-032812-index.htm